Episil-Precision Balance Sheet Health

Financial Health criteria checks 5/6

Episil-Precision has a total shareholder equity of NT$4.9B and total debt of NT$758.1M, which brings its debt-to-equity ratio to 15.5%. Its total assets and total liabilities are NT$6.8B and NT$1.9B respectively. Episil-Precision's EBIT is NT$183.0M making its interest coverage ratio 159.8. It has cash and short-term investments of NT$2.3B.

Key information

15.5%

Debt to equity ratio

NT$758.09m

Debt

Interest coverage ratio159.8x
CashNT$2.28b
EquityNT$4.90b
Total liabilitiesNT$1.91b
Total assetsNT$6.81b

Recent financial health updates

Recent updates

Episil-Precision Inc.'s (TPE:3016) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 21
Episil-Precision Inc.'s (TPE:3016) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Is Episil-Precision (TPE:3016) A Risky Investment?

Feb 23
Is Episil-Precision (TPE:3016) A Risky Investment?

Did The Underlying Business Drive Episil-Precision's (TPE:3016) Lovely 387% Share Price Gain?

Jan 01
Did The Underlying Business Drive Episil-Precision's (TPE:3016) Lovely 387% Share Price Gain?

Financial Position Analysis

Short Term Liabilities: 3016's short term assets (NT$4.3B) exceed its short term liabilities (NT$1.0B).

Long Term Liabilities: 3016's short term assets (NT$4.3B) exceed its long term liabilities (NT$870.8M).


Debt to Equity History and Analysis

Debt Level: 3016 has more cash than its total debt.

Reducing Debt: 3016's debt to equity ratio has increased from 13% to 15.5% over the past 5 years.

Debt Coverage: 3016's debt is well covered by operating cash flow (73%).

Interest Coverage: 3016's interest payments on its debt are well covered by EBIT (159.8x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.